Morgan Levine
Dr. Morgan Levine is a Vice President of Computation and one of the founding Principal Investigators at Altos Labs. Prior to being recruited to Altos, she was a ladder rank professor at Yale University School of Medicine. Levine is considered a leader in the biology of aging, most famous for generating cutting-edge methods for quantifying the molecular and physiological changes that occur over an organism’s lifetime. Her work relies on interdisciplinary approaches, integrating theories and techniques from machine learning and cellular biology to track trajectories aging cells and organisms take over time. Her vision is to develop multi-scale computational models that translate how molecular states of cells drive emergent phenotypes, like health and disease at the tissue, organ-system, or organismal level. Dr. Levine has received numerous awards for her work, including the Vincent Cristofalo Rising Star Award in Aging Research in 2021 and the Nathan Shock New Investigator Award in 2020.
Altos Labs
How Breakthroughs in Cellular Reprogramming Could Transform Aging
-
Epigenetic reprogramming has rapidly become the hottest area in longevity biotech, attracting unprecedented attention and billions in investment in just the last two years. Building on Shinya Yamanaka's Nobel Prize winning iPSC reprogramming, a new wave of biotech startups are now racing to extend the concept to therapeutically rejuvenate the cells in our bodies. This panel brings together the leading researchers and entrepreneurs of this field to explore the science and recent breakthroughs driving the excitement, the challenges of bringing these therapies to market, and the future of a field that could redefine what it means to age.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495